- Coordinates
 - PDB Format
 - Method
 - ELECTRON MICROSCOPY
 - Oligo State
 - hetero-3-3-3-mer
 - Ligands
 - 18 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
 - 3 x NAG- NAG- BMA- FUC: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
 NAG-NAG-BMA-FUC.3: 8 residues within 4Å:- Chain A: G.339, N.343, V.367
 - Chain F: F.124
 - Chain G: S.50, S.51, S.52, G.71
 
1 PLIP interactions:1 interactions with chain G- Hydrogen bonds: G:S.50
 
NAG-NAG-BMA-FUC.10: 7 residues within 4Å:- Chain B: G.339, N.343, V.367
 - Chain H: F.124
 - Chain I: S.50, S.51, S.52
 
2 PLIP interactions:1 interactions with chain I, 1 interactions with chain B- Hydrogen bonds: I:S.50
 - Hydrophobic interactions: B:V.367
 
NAG-NAG-BMA-FUC.17: 6 residues within 4Å:- Chain D: S.50, S.51, S.52
 - Chain E: G.339, N.343, V.367
 
1 PLIP interactions:1 interactions with chain D- Hydrogen bonds: D:S.50
 
- 30 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
 NAG.22: 2 residues within 4Å:- Chain A: Y.28, N.61
 
Ligand excluded by PLIPNAG.23: 2 residues within 4Å:- Chain A: T.108, N.234
 
Ligand excluded by PLIPNAG.24: 2 residues within 4Å:- Chain A: N.164, N.165
 
Ligand excluded by PLIPNAG.25: 3 residues within 4Å:- Chain A: N.280, N.282
 - Chain E: K.558
 
Ligand excluded by PLIPNAG.26: 3 residues within 4Å:- Chain A: N.331, P.579, Q.580
 
Ligand excluded by PLIPNAG.27: 1 residues within 4Å:- Chain A: N.603
 
Ligand excluded by PLIPNAG.28: 1 residues within 4Å:- Chain A: N.616
 
Ligand excluded by PLIPNAG.29: 2 residues within 4Å:- Chain A: H.655, N.657
 
Ligand excluded by PLIPNAG.30: 2 residues within 4Å:- Chain A: N.709, G.1131
 
Ligand excluded by PLIPNAG.31: 4 residues within 4Å:- Chain A: A.706, E.1072, K.1073, N.1074
 
Ligand excluded by PLIPNAG.32: 2 residues within 4Å:- Chain B: Y.28, N.61
 
Ligand excluded by PLIPNAG.33: 2 residues within 4Å:- Chain B: T.108, N.234
 
Ligand excluded by PLIPNAG.34: 2 residues within 4Å:- Chain B: N.164, N.165
 
Ligand excluded by PLIPNAG.35: 3 residues within 4Å:- Chain A: K.558
 - Chain B: N.280, N.282
 
Ligand excluded by PLIPNAG.36: 2 residues within 4Å:- Chain B: N.331, Q.580
 
Ligand excluded by PLIPNAG.37: 1 residues within 4Å:- Chain B: N.603
 
Ligand excluded by PLIPNAG.38: 1 residues within 4Å:- Chain B: N.616
 
Ligand excluded by PLIPNAG.39: 2 residues within 4Å:- Chain B: H.655, N.657
 
Ligand excluded by PLIPNAG.40: 2 residues within 4Å:- Chain B: N.709, G.1131
 
Ligand excluded by PLIPNAG.41: 4 residues within 4Å:- Chain B: A.706, E.1072, K.1073, N.1074
 
Ligand excluded by PLIPNAG.42: 2 residues within 4Å:- Chain E: Y.28, N.61
 
Ligand excluded by PLIPNAG.43: 2 residues within 4Å:- Chain E: T.108, N.234
 
Ligand excluded by PLIPNAG.44: 2 residues within 4Å:- Chain E: N.164, N.165
 
Ligand excluded by PLIPNAG.45: 3 residues within 4Å:- Chain B: K.558
 - Chain E: N.280, N.282
 
Ligand excluded by PLIPNAG.46: 2 residues within 4Å:- Chain E: N.331, Q.580
 
Ligand excluded by PLIPNAG.47: 1 residues within 4Å:- Chain E: N.603
 
Ligand excluded by PLIPNAG.48: 1 residues within 4Å:- Chain E: N.616
 
Ligand excluded by PLIPNAG.49: 2 residues within 4Å:- Chain E: H.655, N.657
 
Ligand excluded by PLIPNAG.50: 2 residues within 4Å:- Chain E: N.709, G.1131
 
Ligand excluded by PLIPNAG.51: 4 residues within 4Å:- Chain E: A.706, E.1072, K.1073, N.1074
 
Ligand excluded by PLIP- Links
 - RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
 - Citation
 - Mannar, D. et al., SARS-CoV-2 variants of concern: spike protein mutational analysis and epitope for broad neutralization. Nat Commun (2022)
          


 - Release Date
 - 2022-08-31
 - Peptides
 - Spike glycoprotein: ABE
Fab S2M11 heavy chain: CFH
Fab S2M11 light chain: DGI - SMTL:PDB
 - SMTL Chain Id:
PDB Chain Id:A
AB
BE
EC
CF
FH
HD
DG
GI
L 
- Coordinates
 - PDB Format
 - Method
 - ELECTRON MICROSCOPY
 - Oligo State
 - hetero-3-3-3-mer
 - Ligands
 - 18 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
 - 3 x NAG- NAG- BMA- FUC: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
 - 30 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
 - Links
 - RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
 - Citation
 - Mannar, D. et al., SARS-CoV-2 variants of concern: spike protein mutational analysis and epitope for broad neutralization. Nat Commun (2022)
          


 - Release Date
 - 2022-08-31
 - Peptides
 - Spike glycoprotein: ABE
Fab S2M11 heavy chain: CFH
Fab S2M11 light chain: DGI - SMTL:PDB
 - SMTL Chain Id:
PDB Chain Id:A
AB
BE
EC
CF
FH
HD
DG
GI
L